Pliant to Present at the 38th Annual Cowen Healthcare Conference

REDWOOD CITY, Calif. – March 6th, 2017 – Pliant Therapeutics, Inc., a company focused on discovering, developing and commercializing breakthrough treatments for fibrotic diseases, announced today that President and Chief Executive Officer, Bernard Coulie, M.D. Ph.D., will present at the 38th Annual Cowen Healthcare Conference being held in Boston, MA from March 12th – 14th, 2018.

Details of the presentation are as follows:

38th Annual Cowen Healthcare Conference
Date: Tuesday March 13th, 2018
Location: Boston, MA Presentation
Time: 2:30 PM ET

About Pliant Therapeutics

Pliant Therapeutics is a pre-clinical stage biotechnology company harnessing the therapeutic capabilities of integrin biology and TGF-β signaling to develop breakthrough treatments for fibrotic diseases. By leveraging its powerful product engine, Pliant’s mission is to prevent or even reverse fibrosis, restoring organ function. The company’s pipeline includes a late preclinical stage proprietary dual selective inhibitor for αVβ6 and αVβ1 integrins. Other, earlier stage programs include integrin and TGF-β signaling targets for multiple fibrotic diseases. For more information, please visit www.pliantrx.com.

Investor Relations Contact:
Mike Zanoni
Trout Group
mzanoni@troutgroup.com
(646) 378-2924